Voltage-gated potassium channel modulation of neurotoxic activity in human immunodeficiency virus Type-1(HIV-1)-Infected macrophages

被引:8
作者
Irvine, Elizabeth
Keblesh, James
Liu, Jianuo
Xiong, Huangui [1 ]
机构
[1] Univ Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Neurophysiol Lab, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA
[3] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
关键词
rnacrophage; voltage-gated potassium channel; 4-anionopyridine; neurotoxin; HIV-1-associated dementia;
D O I
10.1007/s11481-007-9072-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Macrophages play an important role in brain immune and inflammatory responses. They are also critical cells in mediating the pathology of neurodegenerative disorders such as HIV-associated dementia. This is largely through their capacity to secrete a variety of bioactive molecules such as cytokines, leading to neuronal dysfunction and/or death. Accumulating evidence indicates that voltage-gated potassium (Kv) channels play a pivotal role in the modulation of macrophage proliferation, activation, and secretion. Blockade of Kv channels by specific antagonists decreases macrophage cytokine production and ameliorates inacrophage-associated neuronal injury. These results suggest that Kv channels might become a potential target for the development of new therapeutic strategies for chronic inflaminatory diseases.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 48 条
[1]   Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation [J].
Beeton, C ;
Barbaria, J ;
Giraud, P ;
Devaux, J ;
Benoliel, AM ;
Gola, M ;
Sabatier, JM ;
Bernard, D ;
Crest, M ;
Béraud, E .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :936-944
[2]   Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis [J].
Beeton, C ;
Wulff, H ;
Barbaria, J ;
Clot-Faybesse, O ;
Pennington, M ;
Bernard, D ;
Cahalan, MD ;
Chandy, KG ;
Béraud, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13942-13947
[3]   PRELIMINARY TRIAL OF 3,4-DIAMINOPYRIDINE IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
BEVER, CT ;
LESLIE, J ;
CAMENGA, DL ;
PANITCH, HS ;
JOHNSON, KP .
ANNALS OF NEUROLOGY, 1990, 27 (04) :421-427
[4]   THE EFFECTS OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CONCENTRATION-CONTROLLED, CROSSOVER TRIAL [J].
BEVER, CT ;
YOUNG, D ;
ANDERSON, PA ;
KRUMHOLZ, A ;
CONWAY, K ;
LESLIE, J ;
EDDINGTON, N ;
PLAISANCE, KI ;
PANITCH, HS ;
DHIBJALBUT, S ;
FOSSLER, MJ ;
DEVANE, J ;
JOHNSON, KP .
NEUROLOGY, 1994, 44 (06) :1054-1059
[5]   New insights into endotoxin-induced activation of macrophages:: Involvement of a K+ channel in transmembrane signaling [J].
Blunck, R ;
Scheel, O ;
Müller, M ;
Brandenburg, K ;
Seitzer, U ;
Seydel, U .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1009-1015
[7]   BRAIN PATHOLOGY INDUCED BY INFECTION WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) - A HISTOLOGICAL, IMMUNOCYTOCHEMICAL, AND ELECTRON MICROSCOPICAL STUDY OF 100 AUTOPSY CASES [J].
BUDKA, H ;
COSTANZI, G ;
CRISTINA, S ;
LECHI, A ;
PARRAVICINI, C ;
TRABATTONI, R ;
VAGO, L .
ACTA NEUROPATHOLOGICA, 1987, 75 (02) :185-198
[8]   Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia [J].
Cotter, R ;
Williams, C ;
Ryan, L ;
Erichsen, D ;
Lopez, A ;
Peng, H ;
Zheng, J .
JOURNAL OF NEUROVIROLOGY, 2002, 8 (06) :585-598
[9]   Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity [J].
Cotter, RL ;
Burke, WJ ;
Thomas, VS ;
Potter, JF ;
Zheng, JL ;
Gendelman, HE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) :416-427
[10]   Ion channel expression in PMA-differentiated human THP-1 macrophages .3. [J].
DeCoursey, TE ;
Kim, SY ;
Silver, MR ;
Quandt, FN .
JOURNAL OF MEMBRANE BIOLOGY, 1996, 152 (02) :141-157